GlaxoSmithKline plc
980 Great West Road
Brentford,
TW8 9GS
Phone: 44 20 8990 9000
Fax: 44 20 8990 4321
Web Site: http://www.gsk.com
| REUTERS ABRIDGED BUSINESS SUMMARY | |
| GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, over the counter (OTC) medicines, and health related consumer products. The company offers prescription medicines to treat a range of conditions, such as infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer. It also markets approximately 25 vaccines to prevent life-threatening or crippling illnesses, such as hepatitis A, hepatitis B, diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio, typhoid, influenza, and bacterial meningitis. In addition, the company offers OTC medicines, such as alli, a weight loss medicine; Panadol, a paracetamol/acetaminophen analgesic; smoking control products under the NicoDerm, NiQuitin CQ, Nicabate, and Nicorette names; and other brands, including Breathe Right nasal strips and Tums. Its oral healthcare products primarily comprise Aquafresh, a range of toothpastes, toothbrushes, and mouthwashes; Sensodyne, a range of toothpastes and toothbrushes, including Pronamel to protect from acid erosion; Biotene, a treatment for dry mouth; and Polident, PoliGrip, and Corega, which are denture care cleansers and adhesives. Further, the company provides nutritional healthcare products, such as Lucozade, a range of energy and sports drinks; Horlicks, a range of milk-based malted food and chocolate drinks; and Ribena, a blackcurrant juice-based drink. GlaxoSmithKline operates in Europe, North America, Central and South America, the Caribbean, Asia, Australia, the Middle East, Africa, and the Southeast Asia. The company was founded in 1935 and is based in Brentford, the United Kingdom. |
|
| Key Statistics | |
| |
| | Pay | Exercised | Mr. Andrew Witty , 45
Chief Exec. Officer, Exec. Director, Member of Corp. Admin. & Transactions Committee and Member of Fin. Committee |
$
2.74M | N/A | Mr. Julian Heslop , 56
Chief Financial Officer, Exec. Director, Member of Fin. Committee and Member of Corp. Admin. & Transactions Committee |
$
1.45M | N/A | Dr. Moncef Slaoui , 50
Director, Chairman of R&D, Member of Corp. Admin. & Transactions Committee and Member of Fin. Committee |
$
1.75M | N/A | Dr. David Pulman ,
Pres of Global Manufacturing & Supply |
N/A
| N/A | Mr. Marc Dunoyer ,
Pres of Pharmaceuticals Asia Pacific Japan |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.35 (0.92%) 
Profile
Help
